Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Typical (benign) meningioma = WHO grade I
Atypical meningioma (AM) = WHO grade II
Malignant meningioma (MM) = WHO grade III
CT triad of MM: Extracranial mass, osteolysis, intracranial tumor
MR
Dural-based locally invasive lesion with areas of necrosis, marked brain edema
Indistinct tumor margins (tumor invades, interdigitates with brain)
Prominent tumor pannus extending away from mass = “mushrooming”
Marked peritumoral edema
DWI, ADC correlate with hypercellular histopathology (high signal on DWI, low ADC)
Meningioma (typical)
Dural metastasis
Lymphoma
Sarcoma (osteosarcoma, Ewing, gliosarcoma, etc.)
AM: High mitotic activity
MM: AM features + findings of frank malignancy
AM 29% recurrence (26% become MM)
MM 50% recurrence
Difficult to predict meningioma tumor grade on imaging
Imaging findings of typical meningioma do not exclude atypical, malignant variants
Atypical meningioma (AM), malignant meningioma (MM)
Typical (benign) meningioma = WHO grade 1
Common meningioma (CM)
Atypical meningioma = WHO grade 2
Papillary, clear cell meningiomas (CCM)
Malignant meningioma = WHO grade 3
Anaplastic meningioma
Best diagnostic clue
Dural-based, locally invasive lesion with areas of necrosis, marked brain edema
Location
May occur anywhere in neuraxis (brain > > spine)
AM (clear cell variant)
Frequent in CPA, along tentorium
MM
Parasagittal (44%), cerebral convexities (16%) most common sites
Both AM, MM far less frequent in spine, skull base
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here